At one point battling an aggressive leukaemia Abraham Treuhaft was told he may have four weeks to live - now a stem cell ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A game-changing new type of radiation therapy cuts time while improving precision in targeting tumors, a development that ...

Comparison of electron- and proton-based FLASH radiotherapy reveals remarkable similarity in reducing acute skin damage ...

Actinium Pharmaceuticals Inc. has unveiled ATNM-400, a novel non-PSMA-targeting, first-in-class radiotherapy for prostate cancer utilizing the Actinium-225 (Ac-225) radioisotope.

The development of advanced radiotherapy technologies has, in turn, resulted in an increased complexity of operations. Also, a high level of accuracy is needed at every step of the process to achieve ...

Actinium announced ATNM-400, a novel, non-PSMA targeting, first in class radiotherapy for prostate cancer utilizing the Actinium-225 ...

• In advanced-stage HL, reduction of chemotherapy or radiotherapy after a negative interim PET scan is probably beneficial for overall survival. • Treatment escalation with rituximab after a positive ...

Research led by The University of Texas Health Science Center at San Antonio discovers a means of slowing or even blocking recurrence of glioblastoma, the deadliest form of brain cancer.

Discover how isodose MHFRT offers comparable cancer control to CFRT with fewer gastrointestinal side effects, improving patient outcomes.

Early toxicities associated with a 3-week hypofractionated radiotherapy regimen do not raise initial safety concerns in women ...

Advances in cancer treatment have led to increased survival rates among women diagnosed with cancer. However, many cancer ...